Clinical Trial: A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514260) titled 'A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.' on March 31.

Brief Summary: The purpose of this study is to assess the adverse events, tolerability, and Pharmacokinetics (PK) of subcutaneous injections of ABBV-295 in healthy adult Japanese participants with overweight or obesity.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-295

Subcutaneous Injections

DRUG: Placebo for ABBV-295

Subcutaneous Injections

Recruitment Status: RECRUITING

Sp...